Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Vecicom
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vecicom 100mg prolonged-release tablets
0407020AGBFABAD
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 150mg prolonged-release tablets
0407020AGBFACAE
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 200mg prolonged-release tablets
0407020AGBFADAF
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 250mg prolonged-release tablets
0407020AGBFAEAG
|
Vecicom | Tapentadol | Central Nervous System | No data available |
|
Vecicom 50mg prolonged-release tablets
0407020AGBFAAAC
|
Vecicom | Tapentadol | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.